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Background: Surgical site infections (SSIs) remain a common and widespread problem contributing to a significant
morbidity and mortality, attributed partly by the increase in antimicrobial resistance among the etiological agents.
This study was done to determine the spectrum of bacterial isolates and their susceptibility patterns causing SSIs at
Muhimbili National Hospital, Tanzania.
Methods: This descriptive cross sectional study was conducted between September, 2011 and February, 2012. Pus
swabs or pus were cultured on blood agar (Oxoid, UK) and MacConkey agar (Oxoid, UK) and incubated aerobically
at 37°C for 18–24 hours. Bacterial identification was done using API 20E and VITEK and antimicrobial susceptibility
was determined by Kirby Bauer disc diffusion.
Results: Of the 100 patients, from whom wound swabs were collected, 90 (90%) had positive aerobic bacterial
growth. A total of 147 pathogenic bacteria were isolated, including 114 (77.5%) gram negative and 33(22.5%) gram
positive organisms. The most prevalent bacterial species were Pseudomonas aeruginosa (16.3%), followed by
Staphylococcus aureus (12.2%) and Klebsiella pneumoniae (10.8%). Of the 18 S. aureus , 8 (44%) were methicillin
resistant Staphylococcus aureus (MRSA) and three of them (17%) were carrying both MRSA and induced clindamycin
resistance (ICR). Extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae were observed in 23
(79.3%) of the 29 isolates tested. Majority of Escherichia coli 12 (92.3%) and K. pneumoniae 11 (69%) isolates were
ESBL producers. About 63% (93/147) were multiple-drug resistance (MDR) isolates, and the overall MDR among
Gram positive and Gram negative bacteria was 60.6% (20/33) and 61.4%, (73/114), respectively. The prevalence of
MDR for E. coli, A. baumannii and P. stuartii was 100% each. Majority (97%) of the Gram negative bacteria were
resistant to more than four categories (classes) of antibiotics.
Conclusion: A high proportion (63%) of the isolates causing SSIs in this tertiary hospital were MDR, of which (90%)
were resistant to more than four classes of antibiotics. In the light of these findings, an urgent and significant
change in antibiotic prescription policy is required at this National hospital.
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Surgical site infections (SSI) remain a common and wide-
spread problem that contributes to significant morbidity
and mortality, prolongs hospital stay and consequently in-
creasing health care cost [1]. Globally, SSI is reported to
be the third most common nosocomial infection preceded
only by urinary tract infections and pneumonias [1,2]. The
outcome of SSI is partly attributed to increase in anti-
microbial resistant bacterial pathogens [3], which make
the choice of empirical therapy more difficult. Globally,
the incidence of SSIs may range from 1.5 – 20% de-
pending on the diversity and complexity of procedures
performed, age of patients, pre-operative hospitalization,
length of surgery as well as geographical locations [4,5].
SSI remains the major cause of nosocomial infections
in Tanzania that imposes substantial burdens on health-
care resources [6]. Recent studies reported increase of
SSI ranging from 19.4% to 36.5% [7-10], being higher at
Muhimbili National Hospital (MNH) compared to other
referral hospitals [10]. In these studies Staphylococcus aur-
eus was reported to be a predominant pathogen followed
by Escherichia coli, and Klebsiella species with varying
antimicrobial susceptibility patterns. A study at Bugando
Medical Centre (BMC) reported resistance to ciprofloxa-
cin of 86%, 80% and 54% for E. coli, Klebsiella pneumoniae
and S. aureus respectively. Of the E. coli and K. pneumo-
niae involved in SSI at Bugando Medical Centre 65% and
80% were ESBL producers, respectively [7]. Rural settings
have not been spared of the antibacterial drug resistance
problem as shown by a study done (2004) at a remote dis-
trict hospital in Tanzania which reported more than 95%
of S. aureus isolates being resistant to penicillin with 1
(0.8%) being resistant to methicillin [8]. However, recent
data from the same geographical location has revealed sig-
nificant increase of methicillin resistant S. aureus (MRSA)
(18.8%) causing SSI [7].
Previous studies conducted in Tanzania have shown
persistently high levels of antimicrobial resistance in
bacteria isolated from urine and bloodstream infections
[11,12]. However, there is rather limited data regarding
the magnitude and pattern of antimicrobial resistance
among pathogens causing SSI. We undertook this study at
MNH, which is the national referral hospital, and where
antimicrobial use is probably the highest to determine
antimicrobial resistance pattern, including multidrug re-
sistance, among bacteria causing SSI.
Methods
Study design and study setting
This was a descriptive cross sectional study performed
between September, 2011 and February, 2012 at the
Muhimbili National hospital (MNH). Located in Dar es
Salaam, MNH is a 1400-bed facility and the largest hos-
pital in Tanzania, which attends 1000 to 1200 outpatientsa week and serves approximately four million people living
in the Dar es Salaam region. MNH is the main referral
and teaching hospital.
Patient recruitment
All patients with clinical evidence of SSI as defined by
the Centers for disease control and prevention (CDC) [13]
were eligible for the study. Recruitment was done after
obtaining an informed consent. A total of 100 patients
were enrolled consecutively from general surgery, ob-
stetrics and gynecology, and orthopedic wards.
Data collection and laboratory procedures
Structured standard questionnaires were used to obtain
social-demographic and clinical data from patients and
the patient’s case notes. Thereafter two pus swabs or pus
were collected aseptically from the depth of the wound
and transported immediately to the laboratory in Amies
transport media (Oxoid, UK) for processing.
Gram’s stain was performed from the first swab while
the second pus swab was inoculated into blood agar
(Oxoid, UK) and MacConkey agar (Oxoid, UK); and in-
cubated aerobically at 37°C for 18–24 hours. Identifica-
tion was based on microscopic characteristics, colonial
characteristics, and Biochemical tests as described by
Murray et al. [14], including VITEX (BioMerieux, France)
and API 20E (BioMerieux, France). Gram negative organ-
isms were identified by oxidase, Triple sugar Iron (TSI),
sulphur indole and motility (SIM), urease, citrate test, VP
and Methyl red test. Whereas Gram positive organisms
were catalase reaction, coagulase test, DNase test and bile
esculin test.
Antimicrobial susceptibility testing
This was performed by Kirby Bauer disc diffusion method
as described by Clinical and Laboratory Standards
Institute [CLSI] [15]. Briefly test and control organ-
isms (listed below) were suspended in normal saline to
McFarland 0.5 standard and inoculated on Mueller-
Hinton agar [Oxoid, UK]. Appropriate discs were placed
onto the media then incubated at 37°C for 24 hrs.
For Gram positive organisms discs included penicillin
(10 units), ampicillin (10 μg), amoxicillin/clavulanate
(20/10 μg), ceftriaxone (30 μg), gentamicin (10 μg), ery-
thromycin (15 μg), tetracycline (30 μg), ciprofloxacin
(5 μg), clindamycin (2 μg), trimethoprim/sulphamethax-
azole (1.25/23.75 μg) and chloramphenicol (30 μg). The
Gram negative organisms were tested against ampicillin
(10 μg), amoxicillin/clavulanate (20/10 μg), ceftriaxone
(30 μg), ceftazidime (30 μg), cefotaxime (30 μg) gentamicin
(10 μg), tetracycline (30 μg), ciprofloxacin (5 μg), trimetho-
prim/sulphamethaxazole (1.25/23.75 μg), chloramphenicol
(30 μg) and meropenem (10 μg). For P. aeruginosa discs
that were used included ceftriaxone (30 μg), ceftazidime
Figure 1 Isolation frequency of pathogenic bacterial isolates from post-operative wound infections (N = 147).
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floxacin (5 μg) and meropenem (10 μg).
MRSA was determined by disc diffusion test using
cefoxitin (30 μg) disc on Mueller –Hinton Agar, incu-
bated and maintained at 33-35°C for 24 hours, zone of
inhibition ≤ 21 mm was considered a positive result for
MRSA strain [15]. Induced clindamycin resistance among
S. aureus was detected by disc diffusion method on
Mueller-Hinton Agar, where 15 μg of erythromycin disc
and 2 μg of clindamycin disc were spaced 15 mm apart,
incubated at 35 ± 2°C for 16–18 hours. Flattening of the
zone of inhibition adjacent to erythromycin (D-zone) was
interpreted as ICR [15]. ESBLs production was screened
by disc diffusion on Mueller-Hinton Agar with ceftazidime
(30 μg) or cefotaxime (30 μg) and confirmed by double
disc approximation method [15,16]. Quality of media,
antibiotic disc as well as performance of a person carrying
the tests was controlled by reference strains: Escherichia
coli ATCC 25922, K. pneumoniae ATCC 700603 for ESBL,Table 1 Antimicrobial resistance pattern of bacteria isolated
Bacteria isolates (N) Antim
P AP AMC CRO CAZ C
E. coli (n = 13) NA 100 92 92 92 9
K. pneumonia (n = 16) NA 100 94 81 88 8
P. mirabilis (n = 16) NA 73 87 69 67 1
A. baumannii (n = 15) NA 100 100 100 86 1
P. aeruginosa (n = 24) NA NA NA 88 21 N
Other G – (n = 30) NA 90 83 83 57 7
S. aureus (n = 18) 83 92 73 47 NA N
Other G + (n = 15) 67 40 67 50 NA N
G-: Gram negative bacteria [P.stuartii, M.morgannii, P.vulgaris, Enterobacter spp, Citro
AP = Ampicillin, AMC = Amoxycillin/clavulanic acid, CRO = Ceftriaxone, CAZ = Ceftazi
TE = Tetracycline, E = Erythromycin, CD = Clindamycin, CN = Gentamicin, CIP = CiprofS.aureus ATCC 25923, and S.aureus ATCC 29213 for
MRSA.
Multidrug resistant (MDR) was defined as acquired
non-susceptibility to at least one agent in three or more
antimicrobial categories [17]. Antimicrobial categories
tested were Penicillin class (ampicllin, penicillin); Ceph-
alosporin class (ceftazidime, cefotaxime, ceftriaxone);
Aminoglycosides class (gentamicin); Tetracycline class
(Tetracycline); fluorquinolones class (ciprofloxacin); fol-
ate pathway inhibitors class (co-trimoxazole); phenicols
class (chloramphenicol); macrolides class (erythromycin)
and lincosamides class (clindamycin).
Data analysis
Data were entered and analyzed using Epidata Entry
version 3.1 and STATA version 11.2, and expressed in a
descriptive analysis. Categorical variables were compared
using Chi-square test or fisher exact test, p values of < 0.05
was considered significant.from post-operative SSIs
icrobial agents resisted (%)
TX C TS TE E CD CN CP MEM
2 42 85 85 NA NA 92 58 0
8 54 94 56 NA NA 67 56 0
00 69 69 94 NA NA 63 56 0
00 100 77 73 NA NA 86 47 40
A NA NA NA NA NA 8 8 0
6 73 77 65 NA NA 38 47 0
A 20 35 39 17 6 33 29 NA
A 50 42 47 79 25 62 65 NA
bacter spp), G+: Gram positive cocci [CoNS, E.faecalis]. P = Penicillin,
dime, CTX = Cefotaxime, C = Chloramphenicol, TS = Co-trimoxazole,
loxacin, MEM =Meropenem.
Table 2 Multi-drug resistant bacteria isolated from surgical site infections
Bacteria Classes of antimicrobial resisted to N(%) Average
N(%)R3 R4 R5 R6 R7 R8
K. pneumoniae - 1(6.2) 2(12.5) 3(18.8) 8(50) - 14(87.5)
E. coli - 1(7.1) 1(7.1) 2(15.4) 9(62.9) - 13(100)
P. mirabilis - - 1(6.3) 2(12.5) 9(56.2) - 12(75)
A. baumannii 1(6.6) 1(6.6) - 2(13.3) 11(73.3) - 15(100)
P. aeruginosa 1(4) - - - - - 1(4)
P. stuartii - 2(28.6) - 4(57.1) 1(14.3) - 7(100)
Other GNR - - 2(12.5) 3(18.7) 6(37.5) - 11(36.6)
S. aureus 1(5.5) - 2(11.1) 3(16.6) - 2(11.1) 8(44.4)
CONS 2(20) 4(40) - - - 2(20) 8(80)
E. faecalis 1(20) - 2(40) 1(20) - - 4(80)
Total 6(4) 9(6.1) 9(6.1) 20(13.6) 16(10.8) 33(22.4) 93(63)
Key: R3- R7 = resistant to 3, 4, 5, 6 or 7 classes of antimicrobials tested. Other GNR = (M.morgannii, P.vulgaris, Enterobacter spp, Citrobacter spp).
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Ethical approval was obtained from the Senate Research
and Publications Committee of Muhimbili University
of Health and Allied Sciences, Dar es Salaam and a
written informed consent was obtained from each
patient/caretaker.
Results
Demographical – clinical characteristics
We enrolled a total of 100 patients with clinical SSI,
aged between 18 and 80 years. Most of the patients
(53%) were males and nearly half (46%) were from
orthopedic and trauma wards. Regarding surgical proce-
dures, 27% of the patients had surgical debridement and
external fixation, 25% had laparotomy while 15% had
caesarian section (see Additional file 1). Almost all pa-
tients (95%) had documentation of antimicrobial expos-
ure within a month, with ceftriaxone, cloxacillin and
amoxicillin-clavulanic acid the most frequently used,
being prescribed to 80 patients each, followed by genta-
micin (19), ciprofloxacin (17) and metronidazole (15).Figure 2 Trend of pathogenic bacterial isolated from SSI in 2005 andNotably, three-fourth had a history of previous admis-
sion within 6 months.
Etiology of SSI
Of the 100 wound swabs collected, 90% had bacterial
growth. More than half (52.2%, 47/90) had pure bacterial
growth (mono isolate). Gram negative organisms were
more prevalent than gram positive bacteria accounting for
77.5% (114/147) of all isolates. The most predominant
Gram negative organism was P. aeruginosa comprising
16.3% (24/147) of all bacterial isolates. K. pneumoniae
10.8% (16/147) and Proteus mirabilis 10.8% (16/147)
were the next two common Gram negative organisms
[Figure 1]. Most (92.3%) of the 13 Escherichia coli and
11/16 (69%) of K. pneumoniae isolates were ESBLs produ-
cing strains. Of the Gram positive isolates, S.aureus was
the leading cause of SSIs accounting 12.2% (18/147) of all
isolates, followed by coagulase negative Staphylococci
(6.8%) and Enterococcus faecalis (3.4%). Of the 18 S. aureus
isolates, 44.4% (8/18) were MRSA strains and three of
them had induced clindamycin resistance (ICR).2012.
Figure 3 Increasing trend of resistance among Gram negative bacteria isolated from clinical isolates 2004, 2010 and 2012.
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Most of S. aureus isolates were highly resistant (83%) to
penicillins group of antibiotic; some had low to moder-
ate resistance (17% to 33%) to erythromycin, gentamicin
and ciprofloxacin. All Enterobacteriaceae displayed high
magnitude of resistance (69% to 100%) to multiple anti-
biotics tested but all were sensitive to meropenem; and
20-56% were resistant to ciprofloxacin. Surprisingly, 92%
of 24 P. aeruginosa isolates were sensitive to both genta-
micin and ciprofloxacin. Majority of A. baumannii isolates
were highly resistant (73% to 100%) to most antimicrobial
agents; however 60% of them appeared to be moderately
sensitive to imipenem [Table 1]. The magnitude of resist-
ance to gentamicin, ciprofloxacin, co-trimoxazole and
tetracycline was extremely higher in organisms carrying
MRSA (44.4%) and ESBL (79.3%) combined than in non-
carrying isolates [p < 0.001]. Of all isolates 63% (93/147)
were MDR strains, the overall prevalence of MDR strains
was 60.6% among Gram positive and 61.4% among
the Gram negatives. MDR status was displayed in all
Escherichiacoli, A. baumannii and P. stuartii, and 87.5% ofFigure 4 Increasing pattern of resistance to isolates from SSI at MuhiKlebsiella spp. Surprisingly, only one isolate of the 24
P. aeruginosa displayed MDR [Table 2].
Discussion
This report on antimicrobial resistance from the national
hospital in Tanzania demonstrates the predominance of
gram negative bacterial isolates in SSIs (77.5%). Predom-
inately Pseudomonas aeruginosa being the commonest
followed by K. pneumoniae (10.8%) and Proteus mirabilis
(10.8%). On the other hand S.aureus which was the com-
monest Gram positive organism accounted for (12.2%).
This observation is in contrast to finding in previous stud-
ies from the same setting which reported Gram positive
predominantly S. aureus as the most common SSI bacter-
ial pathogen [7,18] (Figure 2).
With regard to antimicrobial resistance we found,
among Gram negative bacteria, very high levels of resist-
ance (73 -100%) to commonly prescribed antibiotics like
ampicillin, amoxicillin/clavulanic acid, co-trimoxazole
and tetracycline, which is in keeping results (32 – 100%)
reported in the same hospital and in Kenya [19,20]. Thembili National Hospital 2005 and 2012.
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terobacteriaceae and Acinetobacter baumannii, showing
an increase in resistance compared to (6.7 – 30%) previ-
ously reported at this hospital in 2004/2010, [11,19]. Re-
sistance to ciprofloxacin is an early warning sign since
fluoroquinolones are effective agents for treatment of
gram negative bacterial infections [21].
With regard to third generation cephalosporins we found
very high levels of resistance (67 -100%) among Gram
negative bacteria, with most of E coli and K. pneumoniae
being ESBL producing strains. These finding is in keeping
with recent studies from Northern-Western Tanzania and
Uganda that shows (61 – 92%) [7,22]. We noted that about
80% of patients received ceftriaxone as prophylaxis, thus
favoring the emergence of resistant bacteria.
Significantly, we note an increasing trend of resistance
to cotrimoxazole, gentamicin, ceftazidime and ciprofloxa-
cin over a period from 2004 to 2012 (Figures 3 and 4)
[11,19]. In addition to the high rate of resistance to indi-
vidual antibiotics, we also found significant number of
MDR isolates. The overall proportion of MDR among
Gram negative bacteria isolates was high (64%), this find-
ing is in agreement with recent study from Uganda [22].
We noted that, all Escherichia coli, Acinetobacter bauman-
nii and Providentia stuartii were MDR strains.
The very high levels of antibiotics resistance seen in this
study could be attributed, at least in part, to inappropriate
use of antimicrobial agents affects both the cost and effi-
cacy, thus favoring the emergence of resistant bacteria.
One of the limitations of our study is cross-sectional
design of the study. Also there was no patient follow up
after discharge up to 30 days which is required accord-
ing to CDC definition of SSI and hence some cases of
SSI after discharge from hospital may be missed.
Conclusion
The very high levels of antimicrobial resistance among
bacteria causing SSIs, including resistant to more than
four categories (classes), complicates the management of
these infections at MNH, and could be associated with
higher SSI rate and prolongation of hospital stay and in-
creased number of drugs usage. There is a very urgent
need of revising the perioperative antimicrobial prophy-
laxis at this national referral Hospital to provide clinicians
with standardized approach to the rational, safe and effect-
ive use of antibiotics management of SSI.
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Additional file 1: Demographic and clinical characteristics of
patients with post-operative wound infections.
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